Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
Insider
Fund
- 2024
- May 1, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Wellington Biomedical Innovation Master Investors (Cayman) II L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Novo Holdings A/S - $10.00M in AVLN purchases and sales in the last 12 months
- SR ONE CAPITAL MANAGEMENT, LLC - $10.00M in AVLN purchases and sales in the last 12 months
- Jill Carroll - $5.00M in AVLN purchases and sales in the last 12 months
- Everett Rand Sutherland - $44K in UPB purchases and sales in the last 12 months
- Aaron Deykin - $19K in UPB purchases and sales in the last 12 months
- Michael Gray - $18K in UPB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Wellington Biomedical Innovation Master Investors (Cayman) II L.P.?
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. is an investment firm of Avalyn Pharma Inc. (AVLN). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Wellington Biomedical Innovation Master Investors (Cayman) II L.P. last file a Form 4?
The most recent primary Form 4 on record is dated 1 May 2026, one of 2 filings going back to 2024.
